System for administering a medicament

1. A system for recommending a dose of a medicament to a patient, comprising:

a medicine delivery pen, comprising:

a body structured to receive a vial of the medicament, the medicament including insulin;

a dispensing mechanism capable of dispensing the medicament;

a sensor capable of determining that the medicine delivery pen is being used and detecting a size of the dose being delivered;

a processor capable of processing dose information;

a power source that powers the processor;

a memory capable of storing dose information; and

a wireless transmitter capable of communicating with a separate companion device; and

a computer program product residing in memory of the companion device, the computer program product comprising instructions, when executed by a process of the companion device, cause the system to implement steps (a)-(e):

(a) determine a blood glucose level of the patient before an administration of insulin via the medicine delivery pen to define a determined blood glucose level;

(b) determine a rate at which the blood glucose level of the patient is rising or falling before an administration of insulin to define a determined blood glucose trend, wherein the determined blood glucose trend is derived from a continuous blood glucose monitor that continuously monitors the blood glucose level of the patient;

(c) based on the determined blood glucose level of step (a) and the determined blood glucose trend of step (b), automatically calculate a recommended dose of insulin to be administered to the patient;

(d) visually present to the patient, via at least one of a display on the medicine delivery pen or a display on the companion device, the recommended dose of insulin to be administered to the patient; and

(e) administer insulin to the patient via the medicine delivery pen in an amount equal to the recommended dose of insulin visually presented to the patient in step (d).

2. The system of claim 1 , wherein the computer program product further comprises instructions, which when executed by the processor of the companion device, cause the system to identify a pattern of the patient's use of the pen and generating notifications if deviations occur from the pattern.

3. The system of claim 1 , wherein the companion device is a mobile electronic device.

4. The system of claim 3 , wherein the mobile electronic device includes a smartphone.

5. The system of claim 1 , wherein the system is configured to allow the information about the administered insulin to be entered into the companion device automatically or manually.

6. The system of claim 1 , wherein the computer program product further comprises instructions, which when executed by the processor of the companion device, cause the system to, prior to administering the insulin to the patient, receive a command indicative of an approval for insulin administration by the medicine delivery pen from a remote third party device.

7. The system of claim 1 , wherein the display on the medicine delivery pen is capable of displaying information recorded or calculated on the companion device and transmitted to the medicine delivery pen.

8. The system of claim 1 , wherein the computer program product further comprises instructions, which when executed by the processor of the companion device, cause the companion device to generate a report of information recorded or calculated on the companion device, wherein the report can be electronically transferred, printed, emailed to a specified address, and/or uploaded to a remote server.

9. The system of claim 8 , wherein the companion device has a contact list to select a contact for transmittal of the report.

10. The system of claim 1 , where information about the administered insulin is viewable in real time remotely by a second companion device via sharing of data over a server.

11. The system of claim 1 , wherein the computer program product further comprises instructions, which when executed by the processor of the companion device, cause the system to determine an amount of insulin on board of the patient before the administration of insulin to define an insulin on board determination, wherein calculation of step (c) includes the insulin on board determination in addition to the determined blood glucose level of step (a) and the determined blood glucose trend of step (b).